Overview
Valvular sclerosis refers to the thickening and calcification of valve leaflets, often seen in aging or chronic conditions, leading to potential valvular dysfunction such as regurgitation. 25Diagnosis
Echocardiography: Essential for assessing valve morphology and quantifying regurgitation severity through methods like Doppler echocardiography and flow convergence analysis. 34
Regurgitant Fraction Calculation: Utilize Doppler echocardiography to calculate regurgitant fraction, correlating well with invasive methods like angiography. 4
Magnetic Resonance Imaging (MRI): Provides accurate measurements of ventricular volumes and can assess regurgitation severity, though valve visualization is limited. 5
Clinical Correlation: Consider non-traumatic causes of subdural hematomas in elderly patients with valvular issues, as they may indicate systemic vascular conditions. 1Management
Angiotensin-Converting Enzyme (ACE) Inhibitors: Effective in reducing regurgitant fraction and improving left ventricular volumes in chronic valvular regurgitation. Consider quinapril at 10-20 mg/day. 2
Non-Invasive Monitoring: Regular echocardiographic follow-up to monitor changes in regurgitant fraction and ventricular function. 34
Sympathetic Denervation Considerations: Monitor for potential exacerbation of medial arterial calcification (Mönckeberg's sclerosis) in patients undergoing sympathectomy, particularly in diabetics. 6Special Populations
Elderly: Increased risk of valvular sclerosis and associated complications; careful clinical assessment for non-traumatic causes of neurological symptoms. 1
Diabetes Mellitus: Higher incidence of Mönckeberg's sclerosis post-sympathetic denervation, warranting close monitoring of arterial calcification. 6Key Recommendations
Utilize Doppler echocardiography for accurate quantification of regurgitant fraction in diagnosing valvular regurgitation severity. (Evidence: Strong 4)
Consider ACE inhibitors like quinapril for managing chronic valvular regurgitation to reduce regurgitant fraction and improve ventricular volumes. (Evidence: Moderate 2)
In elderly patients, exclude non-traumatic causes of neurological symptoms, considering systemic vascular conditions associated with valvular disease. (Evidence: Expert opinion 1)References
1 Ogbuihi S, Fink T. The organized subdural blood clot in forensic case work - a case report. Forensic science international 2000. link00232-2)
2 Schön HR. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation. Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994. link
3 Vandervoort PM, Thoreau DH, Rivera JM, Levine RA, Weyman AE, Thomas JD. Automated flow rate calculations based on digital analysis of flow convergence proximal to regurgitant orifices. Journal of the American College of Cardiology 1993. link90061-5)
4 Rokey R, Sterling LL, Zoghbi WA, Sartori MP, Limacher MC, Kuo LC et al.. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. Journal of the American College of Cardiology 1986. link80146-2)
5 Underwood SR, Klipstein RH, Firmin DN, Fox KM, Poole-Wilson PA, Rees RS et al.. Magnetic resonance assessment of aortic and mitral regurgitation. British heart journal 1986. link
6 Goebel FD, Füessl HS. Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 1983. link